Valganciclovir For Solution
Product Images NDC 59651-444

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 59651-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Valganciclovir Fig1)

Figure 1 (Valganciclovir Fig1)
This appears to be a mathematical formula for calculating two different measures - the Mosteller BSA and the Schwartz Creatinine Clearance. The Mosteller BSA is calculated by multiplying the height of an individual in centimeters with their weight in kilograms, and then dividing the result by 3600. The Schwartz Creatinine Clearance is calculated by dividing the height of an individual in centimeters by their serum creatinine levels in milligrams per deciliter, and then subtracting 2. However, it's difficult to determine the accuracy of this information without a more complete understanding of the context and purpose of these calculations.*
FDA Label Image

Figure 9 (Valganciclovir Fig10)

Figure 9 (Valganciclovir Fig10)
FDA Label Image

Figure 10 (Valganciclovir Fig11)

Figure 10 (Valganciclovir Fig11)
FDA Label Image

Figure 11 (Valganciclovir Fig12)

Figure 11 (Valganciclovir Fig12)
FDA Label Image

Figure 12 (Valganciclovir Fig13)

Figure 12 (Valganciclovir Fig13)
FDA Label Image

Package Label Principal Display Panel Container Label (Valganciclovir Fig14)

Package Label Principal Display Panel Container Label (Valganciclovir Fig14)
Valganciclovir for Oral Solution is a medication that comes in a 100 mL bottle which contains 50 mg valganciclovir per mL. The constituted oral solution should be used within 4 hours of preparation and stored under refrigeration. It is important to use valganciclovir as directed by a doctor. The medication comes with a package insert that has more information about the dosage. This product is distributed by Aurobindo Pharma and was made in India.*
FDA Label Image

Package Label Principal Display Panel Carton Label (Valganciclovir Fig15)

Package Label Principal Display Panel Carton Label (Valganciclovir Fig15)
This is a description of Valganciclovir for Oral Solution with an NDC number of 59651-444-01. It is only available by prescription. The package contains a new oral dispenser and each mL of the oral solution contains 50 mg of valganciclovir free base. The text provides instructions for the pharmacist and dosage information for patients. The image quality is not clear.*
FDA Label Image

Figure 1 (Valganciclovir Fig2)

Figure 1 (Valganciclovir Fig2)
The text describes an oral dispenser with child-resistant properties including a bottle adapter. A figure is referenced as "Figure 1".*
FDA Label Image

Figure 2 (Valganciclovir Fig3)

Figure 2 (Valganciclovir Fig3)
FDA Label Image

Figure 3 (Valganciclovir Fig4)

Figure 3 (Valganciclovir Fig4)
FDA Label Image

Figure 4 (Valganciclovir Fig5)

Figure 4 (Valganciclovir Fig5)
Not available.*
FDA Label Image

Figure 5 (Valganciclovir Fig6)

Figure 5 (Valganciclovir Fig6)
FDA Label Image

Figure 6 (Valganciclovir Fig7)

Figure 6 (Valganciclovir Fig7)
FDA Label Image

Figure 7 (Valganciclovir Fig8)

Figure 7 (Valganciclovir Fig8)
FDA Label Image

Figure 8 (Valganciclovir Fig9)

Figure 8 (Valganciclovir Fig9)
FDA Label Image

Chemical Structure (Valganciclovir Str)

Chemical Structure (Valganciclovir Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.